ELANE and chronic obstructive pulmonary disease: Accordingly, AAT controls tissue degradation promoted by proteases, especially neutrophil elastase, and inhibits the action of these pro-inflammatory enzymes on specific tissues, such as the effect of neutrophil elastase in lungs, with a described role on the COPD and emphysema (15–17, 20, 35–38).